GeoVax Signs $1 Million Revolving Loan; Five Directors Resign, Three Lender Nominees Join
GeoVax entered a revolving loan agreement dated October 25, 2026 with Bowery Consulting Group Inc. for up to $1 million outstanding at one time, at 12% interest, with no amount borrowed as of the filing. The lender can refuse any drawdown at its sole discretion, and either party can terminate the commitment. Five directors resigned effective October 23, 2026, and three lender-designated nominees now make up three of the five board seats, so shareholders should note both the costly, contingent financing and the shift in board control.
Key points
- Loan facility of up to $1 million at 12% per annum, due on the first anniversary of closing; no amount borrowed as of the filing date
- Lender may refuse any drawdown in its sole discretion, and either party may terminate the commitment at any time
- Directors Randal Chase, Dean Kollintzas, Nicole Lemerond, Jayne Morgan and John Spencer, Jr. resigned effective October 23, 2026; Steven Brown, Tyler O'Brien and Manpreet Uppal were appointed as lender nominees
- Nominees automatically resign if the initial public equity offering is not closed within ten business days after the S-1 becomes effective, or if at least $10 million in total financing is not completed by December 31, 2026
The filing
Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 27, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.